ARC Conference 2017

Delegates from all parts of the UK gathered at the Manchester Conference Centre on 16-17 May for the annual general meeting of the Association of Revenue and Customs (ARC), the section of the FDA representing members in HM Revenue and Customs.
Chaired by ARC President Vicky Johnson, the AGM debated 83 motions on topics a diverse as government pay policy, hot desking, managing Brexit and changes to travel allowances.
Delegates voted to end ARC’s long-standing political fund and backed motions calling for an end to the government’s 1% cap on pay rises and a return to pay progression for staff within the existing pay bands.
The conference’s liveliest debate came on a motion calling on the ARC Committee to set up an informal ‘buddy support system’ for members taking career breaks. After a fiercely contested debate, delegates eventually backed the motion’s claims that existing support systems set by the department to keep staff on career breaks in touch with developments at work were inadequate.
But a motion calling for ARC to explore the possibility of exchanging some terms and conditions in return for HMRC being treated as a “special case” in pay negotiations was rejected by delegates.
Delegates also heard keynote speeches from FDA General Secretary Dave Penman and Paul Novak, Deputy General Secretary of the TUC, who spoke about the future of trade unions and the workforce in the aftermath of Brexit.
Related News
-
Under significant pressure: Interview with Director of Public Prosecutions
Tom Nathan speaks to Crown Prosecution Service Director of Public Prosecutions Stephen Parkinson about CPS’s handling of riots, the importance of impartiality and his plan to help reduce unmanageable prosecutor caseloads.
-
Changing the culture
HM Chief Inspector Sir Martyn Oliver sat down for an ‘in conversation’ event with FDA General Secretary Dave Penman, discussing the pace of change in Ofsted, challenging perceptions and tackling the long hours culture in Education.
-
Hybrid working: Led by evidence, not headlines
Tom Nathan shares the findings and recommendations of the FDA’s recent report on ‘The future of office working in the civil service’.